文献速递儿科影像技术与安全CT

儿童接受低渗碘对比剂后恶心呕吐的发生率及危险因素:聚焦准备性禁食

Incidence and Risk Factors of Nausea and Vomiting after Exposure to Low-Osmolality Iodinated Contrast Media in Children: A Focus on Preparative Fasting.
PubMed 文献 · Korean J Radiol · 2020-08-04

该研究纳入2017年4月至2019年7月行增强CT的864名儿童,评估静脉注射低渗碘对比剂后恶心呕吐的发生率及危险因素。结果显示2.1%的儿童出现恶心呕吐,禁食时长与恶心呕吐无关,而正在进行的化疗以及使用碘美普尔或碘海醇是独立危险因素。

要点

  • 儿童增强CT后恶心呕吐发生率低(2.1%),未发生吸入性肺炎。
  • 禁食时长与恶心呕吐无关,但许多儿童经历了过度禁食。
  • 正在进行的化疗及使用碘美普尔或碘海醇是恶心呕吐的独立危险因素。

诊断标准与关键数值

  • 864名儿童中18名(2.1%)发生恶心呕吐并发症,其中6名仅恶心,12名恶心伴呕吐。
  • 发生恶心呕吐的患者平均禁食时长为7.9±5.7小时(范围3-21小时),无恶心患者为8.7±5.7小时(范围0-24小时),禁食时长与恶心呕吐无关(p=0.634)。
  • 多因素logistic回归显示,正在进行的化疗(OR=4.323;95%CI=1.430-13.064;p=0.009)、使用碘美普尔(OR=7.219;95%CI=1.442-36.146;p=0.016)和使用碘海醇(OR=5.241;95%CI=1.350-20.346;p=0.017)是恶心呕吐的独立危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the incidence and risk factors of emetic complications associated with the intravenous administration of low-osmolality iodinated contrast media (ICM) in children undergoing computed tomography (CT).

MATERIALS AND METHODS: All children who underwent contrast-enhanced CT between April 2017 and July 2019 were included. Pediatric patients were instructed on the preparative dietary protocol at our institution. Experienced nurses in the radiology department monitored the children during the CT scans and recorded any emetic complications in their electronic medical records. These data were used to calculate the incidence of emetic complications. Various patient factors and technical factors, including fasting duration, the type and volume of ICM, and ongoing chemotherapy, were evaluated to identify risk factors for emetic complications using univariate and multivariate logistic regression analyses.

RESULTS: Among the 864 children (mean age, 8.4 ± 5.7 years) evaluated, 18 (2.1%) experienced emetic complications (6 experienced nausea only and 12 experienced nausea and vomiting). None of the children developed aspiration pneumonia. The mean fasting duration of patients with emesis was 7.9 ± 5.7 hours (range, 3-21 hours), whereas that of patients without nausea was 8.7 ± 5.7 hours (range, 0-24 hours). Fasting duration was not associated with the development of nausea and vomiting (p = 0.634). Multivariate logistic regression analysis revealed that ongoing chemotherapy (odds ratio [OR] = 4.323; 95% confidence interval [CI] = 1.430-13.064; p = 0.009), iomeprol use (OR = 7.219; 95% CI = 1.442-36.146; p = 0.016), and iohexol use (OR = 5.241; 95% CI = 1.350-20.346; p = 0.017) were independent risk factors for emetic complications.

CONCLUSION: Only a small proportion (2.1%) of children experienced nausea or vomiting after exposure to low-osmolality ICM. Many children underwent excessive fasting; however, fasting duration was not associated with nausea and vomiting. Moreover, ongoing chemotherapy and the use of iomeprol or iohexol were identified as potential risk factors for emetic complications in children.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Ha JY, Choi YH, Cho YJ, et al. Incidence and Risk Factors of Nausea and Vomiting after Exposure to Low-Osmolality Iodinated Contrast Media in Children: A Focus on Preparative Fasting. Korean J Radiol. 2020. PMID: 32767861. doi:10.3348/kjr.2019.0835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。